End Markets
Industry Expands Again
January was the third month in a row and the fifth time in six months that index was higher than it was one year ago.
Read More
Motor Vehicles & Parts Production to Slow in 2014
The numbers look good now, but moving forward there are reasons to be cautious about the auto industry.
Read More
The Truth About Reshoring
Reshoring is not just a buzzword, it’s an economically driven correction to a supply chain that had become unbalanced.
Read More
Five-Layer Line Gives Processor More Flexibility, New Opportunities
Processor bumps it up from three-layers to boost quality, flexibility and enter new markets.
Read More
New Player in Enhanced PLA Compounds, Additives
Floreon of the U.K. offers -impact-modified PLA that's more than 90% biobased, as well as additive masterbatches.
Read More
Milacron acquires Kortec building its coinjection portfolio
Milacron is building an impressive injection technology portfolio that will give it greater reach into packaging markets.
Read More
How ‘sticky’ is your business?
Medical means less cyclicality and higher margins—those are two broadly agreed upon assumptions about the market—but is there another aspect that keeps processors pushing to enter the space?
Read More
Study Ranks Phthalates, Alternatives for Medical Devices
Now there's a clearer understanding of how a specific change of plasticizer may impact the performance of a non-PVC medical device.
Read MoreMATERIALS: Nexus to Distribute Chinese PET
San Francisco-based Pacific Rim Traders (PRT), the sales and service arm in the Americas for China’s Dragon Special Resin Co.’s PET resins, has chosen the Nexus Resin Group, Mystic, Conn., as its exclusive distributor.
Read More
Floreon Has New Investors for "Performance" Bioplastic; Aims to Hit U.S. Soon
Floreon Transforming Packaging of Hull, U.K., has secured multiple new investors through an Enterprise Investment Scheme (EIS) to bring its patent-pending “performance” bioplastic material to market, and the U.S. is its prime regional target.
Read More
